, an investment firm focused on life sciences, has named Dr. Brian Gallagher
as a partner. Previously, he worked at SR One
, the venture capital arm of GlaxoSmithKline,
where he was a partner
and established the company’s Boston office. Gallagher will be based in Abingworth’s Boston office.
London, UK, 21 September 2018 – Abingworth, the international investment group dedicated to life sciences, today announced that Brian Gallagher, PhD, will join Abingworth as a Partner based in the company’s Boston office. Brian has more than 20 years of investing, business development, operational and R&D experience in both biotechnology and large pharmaceutical companies.
He will work with the team in the London and Menlo Park offices to source and support deals across a wide range of therapeutic areas and stages of development from start-ups to late-stage venture capital investments.
Brian joins from SR One, the venture
Continue reading "Abingworth taps Gallagher as a partner for Boston office"
Austin, Texas-based SparkCognition
, an artificial intelligence company, has named Vijay Doradla
as chief business officer. Previously, Doradla was lead director at Verizon Ventures
. The investors included Verizon Ventures, The Boeing Company, CME Ventures, Brevan Howard Investment Holdings Limited
and Invenergy Future Fund.
AUSTIN, Texas, Sept. 21, 2018 /PRNewswire/ — SparkCognition has announced the addition of Vijay Doradla to its leadership team as Chief Business Officer. Doradla brings decades of diverse experience in technology and innovation to SparkCognition from serving in engineering, research, and investment roles.
“SparkCognition is at the forefront of the world’s greatest technological shift, pioneering the application of artificial intelligence for society’s most critical industries,” said Doradla. “I am honored to be a part of the team shaping the AI 3.0 revolution. I’m thrilled to join SparkCognition in building AI to advance the most important interests of society.”
With over 20 years of
Continue reading "VC-backed AI company SparkCognition hirs chief business officer"
has named Amy Thiessen
as director of business development in North America. Previously, she was a principal at Park Madison Partners.
New York, NY, September 20, 2018. HQ Capital has hired Amy Thiessen as Director of Business Development to lead capital raising and business development in North America. She will be based in New York.
Amy will raise capital and develop new strategic partnerships across HQ Capital’s platform with institutional investors in North America including pension funds, sovereign wealth funds, family offices, endowments and foundations. She will also manage existing strategic partnerships with groups in the U.S. and Canada.
Amy joins HQ Capital with 13 years of experience in capital markets in Europe and the U.S. Previously, she was a Principal at Park Madison Partners, raising capital for global real estate private equity strategies. From 2013 to 2015, Amy was a Managing Director at
Continue reading "HQ Capital taps Thiessen as business development VP"
McDonald Hopkins LLC
, a business advisory and advocacy law firm, has hired Jordan Koss
to head its startup and venture capital group. Previously, Koss worked at Goodcounsel LLC.
CHICAGO, Sept. 19, 2018 /PRNewswire/ — Jordan Koss has joined the Chicago office of McDonald Hopkins LLC as a member and will be the head of the firm’s startup and venture capital group. He comes to McDonald Hopkins from goodcounsel LLC, a top boutique firm in Chicago focused on early stage startup representation, with prior experience at Fenwick & West in San Francisco and Kirkland & Ellis in New York.
“Jordan brings to McDonald Hopkins a dynamic and growing practice of representing venture capital and venture capital-backed companies,” said David A. Agay, the managing member of the firm’s Chicago office and a member of the Board of Directors. “We are extremely excited to have Jordan join the firm. His
Continue reading "McDonald Hopkins hires Koss to head startup and VC group"
San Francisco-based Blumberg Capital
, an early-stage venture firm, has added six new staffers to its team. Joining Blumberg are Steve Gillan
as chief operating officer and chief financial officer in San Francisco; Yodfat Harel Buchris
as managing director in Tel Aviv; Ehud Schneorson
as managing director in Tel Aviv; Idan Nurick
as principal in Tel Aviv; Andrew Van Nest
as associate in San Francisco; and Peter Cooney III
as data analyst in San Francisco.
SAN FRANCISCO and TEL AVIV, Sept. 20, 2018 /PRNewswire/ — Blumberg Capital, a San Francisco based early-stage venture capital firm, today announced a significant expansion, adding six new team members in Tel Aviv and San Francisco. The new members bring a combination of deep operational, entrepreneurial and technical expertise that will greatly help the firm expand its global investment breadth as well as support current portfolio companies.
“We take great pride in
Continue reading "Blumberg Capital beefs up team with six new hires"
Toronto, New York and Cambridge, Massachusetts-based BlueRock Therapeutics LP
, a cell therapy company, has appointed Shane Kovacs
as both chief business and chief financial officer. Previously, he was managing director, head of biotechnology investment banking at RBC Capital Markets
in New York. BlueRock was backed by Bayer AG
and Versant Ventures.
CAMBRIDGE, Mass., Sept. 20, 2018 /PRNewswire/ — BlueRock Therapeutics, LP, an engineered cell therapy company focused on leveraging its novel Cell+Gene platform to develop regenerative medicines for intractable diseases, today announced the appointment of Shane Kovacs as both Chief Business and Chief Financial Officer. In his new role, Mr. Kovacs will help define and execute the vision of BlueRock to develop and apply its Cell+Gene platform across multiple therapeutic areas. Mr. Kovacs brings strong biotech operating experience combined with significant investment banking and capital markets expertise.
“Our engineered cell therapy platform enables us to design
Continue reading "VC-backed BlueRock Therapeutics adds Kovas to C-suite team"
Meketa Investment Group
has named David Eisenberg
and Bradley Regier
were director of consulting services and director of business management, respectively. Also, earlier this year, the investment consulting firm hired Rita McCusker
as a senior vice president and director of client services.
BOSTON – September 19, 2018 -Meketa Investment Group, a global investment consulting firm, is pleased to announce three new management positions at the firm. Last month, Principals David Eisenberg and Bradley Regier were named Director of Consulting Services and Director of Business Management, respectively. In addition, Rita McCusker joined the firm as a Senior Vice President and Director of Client Service earlier this year. The three positions report to Meketa Investment Group’s co-CEOs Stephen McCourt and Peter Woolley.
Working closely with other senior executives at Meketa Investment Group, Mr. Eisenberg is responsible for deployment of consulting resources, workflow, team assignments, and staff development. Mr. Eisenberg’s 35
Continue reading "Meketa Investment expands team with new appointments"
Tower Arch Capital LP
said Sept. 20 that Steve Smith
has joined the firm as vice president of business development. Smith previously North American self-reliance operations for a non-profit.
SALT LAKE CITY, Sept. 20, 2018 /PRNewswire/ — Tower Arch Capital, L.P., a leading lower-middle market private equity fund that partners with entrepreneurs and family-owned companies to create long-term value for its management team and investors, announced today that Steve Smith has joined the firm as Vice President of Business Development.
Mr. Smith brings more than 18 years of experience in sales, private equity, investment banking, and management executive leadership. Prior to joining Tower Arch, he co-led the North American Self-Reliance operations for a large non-profit. Previously, he was a Vice President at private equity firm HGGC and worked in the M&A group at CIBC World Markets. Mr. Smith holds a Bachelor of Science in Finance from the University of Utah.
Continue reading "Smith joins Tower Arch Capital"
Gemini Bioproducts LLC
, a portfolio company of BelHealth Investment Partners LLC
, has appointed Dale Gordon
as its CEO. Gordon was previously commercial general manager at GE Healthcare Life Sciences
, a unit of GE
New York, New York and West Sacramento, CA – September 19, 2018 – Gemini Bioproducts, LLC (“Gemini” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, announced the appointment of Dale Gordon as Chief Executive Officer (“CEO”). Gemini was founded in 1985 by Bertram Polan, who grew the Company from the ground up to its national and international footprint today. Mr. Polan will continue with the Company as Chairman of the Board.
Dale Gordon has over 27 years of experience in the life science industry. Notably, for 24 years, Mr. Gordon held various commercial leadership roles at MilliporeSigma, a subsidiary of Merck
Continue reading "Gordon named CEO at Gemini Bioproducts"
and Mark Brubaker
are joining Point72
as senior executives. O’Connor will become COO and CFO of Point 72, while Brubaker will become chief technology officer. O’Connor most recently was COO of Goldman Sach
‘s investment management division. Brubaker was previously global head of equities technology at Millennium Partners
STAMFORD, Conn.–(BUSINESS WIRE)–Point72, L.P. (Point72) has announced that Gavin O’Connor and Mark Brubaker will join the Firm as senior executives, Point72’s CEO and President Steve Cohen announced today.
Mr. O’Connor, who joins Point72 from Goldman Sachs, will become the Point72 Group Chief Operating Officer and Chief Financial Officer. Mr. Brubaker, who most recently served as Millennium Partners’ Global Head of Equity Technology and Shared Services, will join Point72 as its new Chief Technology Officer.
“Gavin and Mark are experienced leaders who will bolster our ability to innovate and operate at the highest levels of professionalism, integrity,
Continue reading "O’Connor, Brubaker join Point72"
, which is backed by Bain Capital Private Equity
, has promoted Jill Parrino
to chief operating officer. Previously, she was the vice president of solutions and innovation. Detroit-based GRI is an independent extended workforce solutions provider.
DETROIT, Sept. 18, 2018 /PRNewswire/ — Jill Parrino has been named Chief Operating Officer at GRI, now leading the company’s expanded efforts to provide a range of programs that will better-serve clients and offer an expanded set of strategic solutions. A veteran of the non-employee labor industry, she spent the past four years as GRI’s Vice President of Solutions and Innovation, leading her team to generate an entire slate of solutions, services, training tools, and best practices that bolstered the company’s position as an industry leader.
“After spearheading the development of GRI’s innovative solutions, this is an incredible opportunity to shift my focus to further implement those, bringing greater
Continue reading "PE-backed GRI promotes Parrino to COO"
, which is part of JMP Group
, an investment banking and alternative asset manager, has named Shawn Cross
as managing director in its healthcare investment banking group. Previously, he was was chairman and CEO of GT Biopharma.
SAN FRANCISCO–(BUSINESS WIRE)–JMP Group LLC (NYSE: JMP), an investment banking and alternative asset management firm, announced today that Shawn Cross has joined JMP Securities as a managing director in its healthcare investment banking group. Based in the firm’s San Francisco office, Mr. Cross will concentrate on the biotechnology and biopharmaceutical sectors.
“Shawn brings over two decades of experience to JMP Securities’ healthcare group,” said Carter Mack, president of JMP Group. “He has held senior investment banking positions at top Wall Street firms and has also spent time in executive roles in industry. Shawn’s extensive knowledge of the biotech and biopharma spaces, as well as the associated capital markets
Continue reading "JMP Securities recruits Cross as MD for healthcare group"
said Sept. 18 that Jennifer Zhao
has joined the firm as vice president, investor relations. Zhao was previously a vice president in the fundraising group at TPG
SAN FRANCISCO, September 18, 2018 – Genstar Capital, a leading private equity firm focused on investments in targeted segments of the software, industrial technology, healthcare, and financial services industries, today announced the appointment of Jennifer Zhao as Vice President, Investor Relations.
Tony Salewski, Managing Director at Genstar, said, “Jennifer joins Genstar at a very exciting time for our firm, as we continue our growth following the closing last year of the largest fund in our history. Jennifer’s proven talent and background will help further Genstar’s best practices in investor relations, and we look forward to benefiting from her expertise as we strengthen existing partnerships with our limited partners and develop new relationships with investors who share our goal
Continue reading "Zhao joins Genstar"
Benhamou Global Ventures
said Sept. 18 that it promoted Yashwanth Hemaraj
to Partner in Palo Alto. The firm hired Susan Boehnlein
as its CFO, while Sarah Benhamou
joined as an associate. The early-stage VC firm said it is also launching Arka Venture Labs in partnership with Blume Ventures
and Emergent Ventures
Palo Alto, CA – September 18, 2018 – Benhamou Global Ventures (BGV), an early-stage venture capital firm with deep Silicon Valley roots and an exclusive focus on the digital transformation of the enterprise with a cross-border innovation theme, announced the expansion of its team with promotion of Yashwanth Hemaraj to Partner in Palo Alto, and the hiring of CFO Susan Boehnlein in Palo Alto, and associate, Sarah Benhamou in Paris, France.
In addition to the team expansion, BGV expands its outreach to entrepreneurs with the launch of Arka Venture Labs in partnership with Blume Ventures and Emergent
Continue reading "Benhamou Global promotes Hemaraj to partner"
has joined H.I.G. Capital
’s capital formation group as a principal based in Hong Kong. Park will be responsible for capital raising and investor relations in Asia and Australia. Most recently, he spent five years at Oaktree Capital
in Hong Kong, covering the Asian markets for Oaktree’s private equity, credit, real estate and infrastructure products.
NEW YORK–(BUSINESS WIRE)–H.I.G. Capital, a leading global alternative asset investment firm with over $27 billion of equity capital under management, is pleased to announce that Ken Park has joined the firm’s Capital Formation Group, as a Principal based in Hong Kong. Mr. Park will be responsible for capital raising and investor relations in Asia and Australia, across the firm’s private equity, growth equity, credit and real estate strategies.
Ken has held several leadership positions prior to his appointment at H.I.G. Most recently, Ken spent the
Continue reading "Park joins H.I.G. Capital’s capital formation group"
Paine Schwartz Partners LLC
has named Steve Bierschenk
as a managing director on the investment team. Previously, he worked at Monsanto
where he most recently served as a member of the global strategy leadership team.
SAN MATEO, Calif., Sept. 17, 2018 /PRNewswire/ — Paine Schwartz Partners, LLC, (“Paine Schwartz”), a global leader in sustainable food chain investing, today announced that Steve Bierschenk is joining the firm as a Managing Director on the investment team, effective Monday, September 17, 2018. Mr. Bierschenk comes to Paine Schwartz after 18 years at Monsanto, where he most recently served as a member of the Global Strategy Leadership Team and helped drive the company’s competitive strategy, vegetable business strategy and emerging growth platforms.
Kevin Schwartz, Chief Executive Officer and a Founding Partner of Paine Schwartz, said, “We are continuing to bolster the domain expertise and operating experience of our team as we
Continue reading "Paine Schwartz Partners appoints Bierschenk as MD"
has promoted Peter L. Clark Jr.
and Alan C. Welch Jr.
to partner from principal. Clark joined the firm in 2003 while Welch came on board in 2008.
September 17, 2018 – Charlotte, North Carolina – Carousel Capital announced today that Peter L. Clark, Jr. and Alan C. Welch, Jr. were named Partners at the firm, effective immediately. Both are being promoted from their current roles as Principals with the firm.
“We have worked hard to build Carousel Capital with the right people and are pleased to name Peter and Al as Partners for the firm – the first such promotions in over a decade,” said Charles S. Grigg, Managing Partner. “Jason and I have enjoyed working with Al and Peter for 10 and 15 years, respectively, and have watched them grow into investment professionals that understand what it truly means to partner with Carousel’s management
Continue reading "Carousel promotes two to partner"
, which is backed by Kohlberg & Company
, has named Robert G. Isaman
as president and CEO. He is taking over from Jeffery Stark
who will become chairman of the board of directors. Based in Cincinnati, Senneca is a maker of specialty doors and enclosures for commercial and industrial end markets.
CINCINNATI–(BUSINESS WIRE)–Senneca Holdings, Inc. (“Senneca” or the “Company”), the leading North American manufacturer and distributor of specialty doors and enclosures for commercial and industrial end markets, announced that, effective today, Robert (Bob) G. Isaman has been named the Company’s President & Chief Executive Officer. Isaman assumes this role from Jeffery Stark, Senneca’s current Chief Executive Officer, who will become Chairman of the Board of Directors of Senneca. Under Stark’s leadership, Senneca achieved significant growth and completed multiple acquisitions, positioning the Company for its recent acquisition by Kohlberg & Company LLC. In his role as Chairman,
Continue reading "PE-backed Senneca appoints Isaman as president/CEO"
Law firm Goodwin
has named Daniel Lindsey
as a partner in its private equity practice. Lindsey will be based in Hong Kong.
HONG KONG–(BUSINESS WIRE)–Global law firm Goodwin announced today that Daniel Lindsey has joined the firm’s Hong Kong office as partner in its Private Equity practice.
Lindsey has extensive experience on a variety of debt finance transactions across Asia and Europe acting for borrowers, lenders, financial advisers and special committees, with a particular focus on private equity driven, cross-border leveraged finance transactions with public and private company targets. His experience also extends to margin loans, minority ‘back leverage’ financings, mezzanine financings, fund-level financings, syndicated facilities and loan restructurings.
“Daniel joins Goodwin as we continue to strengthen our Asia offering by providing comprehensive transactional advice to our clients, mainly private equity firms and technology, media and life sciences companies,” said Yash Rana, Chair of Goodwin’s Hong Kong office.
Continue reading "Goodwin beefs up PE practice with new hire"
has named Matthew Kretzman
as a managing director responsible for capital markets and execution across the North American private equity portfolio. Previously, Kretzman worked at KKR
where he was recently a director in the credit and markets unit.
MIAMI–(BUSINESS WIRE)–H.I.G. Capital (“H.I.G.”), a leading global private equity investment firm with over $27 billion of equity capital under management, is pleased to announce that Matthew Kretzman has joined H.I.G.’s New York office as a Managing Director responsible for capital markets and execution across the North American private equity portfolio.
Matthew has more than ten years of capital markets experience. Prior to joining H.I.G., he spent over six years at KKR where he was most recently a Director in the Credit & Markets division, responsible for private debt and capital markets origination and execution for
Continue reading "H.I.G. recruits Kretzman as MD"